The use of surgical robots offers a wide range of possibilities, but in Europe the technology is often unable to reach its full potential. Dr. med. Christoph Wandhöfer explains why.
While the Medical Device Regulation was designed to enhance safety and quality, its complexity and certification costs threaten the availability of vital devices. Cardiologists urge for revision.
Assistive AI systems are designed to ease the workload of physicians. However, implementation of the technology could actually worsen challenges related to error prevention and burnout, experts warn.
For more than a year now, patients in Austria are no longer required to wear a lead apron during radiological imaging procedures such as X-ray and CT scans. However, the new recommendation, issued by the country's five specialist societies for radiation protection and imaging, has sparked mixed reactions among radiology technologists. At the annual congress of the specialist society…
ChatGPT has brought generative AI to the mainstream – and into many GP practices as well, a new study suggests. The work points out the risk of doctors using AI without clear guidance or policies.
Managing Directors and C-level executives from hospitals, clinics, and healthcare facilities gather in Berlin to discuss the latest advances and strategies for the digitalisation of healthcare.
The pace of artificial intelligence (AI) adoption in personalised medicine is unsettling for great parts of the public. A new survey reflects the worried state of mind in the UK.
Medical AI is advancing gastrointestinal endoscopy – but what happens when it contributes to a medical error? Legal experts are pioneering efforts to develop guidelines on medical AI liability.
Generalist Medical Artificial Intelligence (GMAI) models pose a significant challenge to current regulatory frameworks. Experts discuss how regulation of these models could work in the future.
AI technology holds promise for personalised cancer therapies. However, rigid and slow approval requirements impede its introduction, say experts – and point out how this might be changed.
Digital pathology brings benefits for sample management and optimisation, lets pathologists work on samples remotely: The UK Government has now approved the use of the technique for cancer samples.
UK law changes threaten the security of messaging apps – and their use in the NHS. Doctors warn that patient care will suffer if they can no longer use apps such as WhatsApp to share information.
It's an important milestone for gene editing technology: a novel treatment for sickle cell disease utilizing CRISPR-Cas9, has now received FDA approval – a first for this type of therapy.
According to the European Dementia Monitor, there is still a clear East/West divide, with significant differences between countries in terms of availability, affordability, legal and human rights.
Sure, AI still has a long way go. But maybe one day in the not-so-distant future, AI will provide us with information about our current state of health, such as the number of red blood cells, cholesterol levels, fat percentage, and how many seconds last night's beer will shorten our life expectancy.
Under the impulse of the European Commission, the in vitro diagnostic industry is developing emerging technologies to implement sustainable practices in medical laboratories. As sustainability has been a growing priority of the European Union (EU) in the last decade, ‘the medical technology sector, particularly the IVD sector, must comply with European legislation in this field like all other…
LLM-based generative chat tools such as ChatGPT or Google’s MedPaLM have great medical potential, but there are inherent risks associated with their unregulated use in healthcare.
January 28 saw the celebration of the “Data Protection Day” as it is called in Europe, or respectively the “Privacy Day” as it is referred to outside of Europe. It marks the date on which the Council of Europe’s data protection convention, known as “Convention 108” was opened for signature back in 1981. According to the Council of Europe, it is the ‘only international,…
Current EU regulation does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from Finland concludes.
